ANKENY, Iowa, May 27, 2008 -- Embria(R) Health Sciences, a raw material manufacturer of science-backed natural ingredients for the human nutrition market, announced today it has been honored with the Ankeny Economic Development Corporation's 2008 Commercial Investment Award. This is the fourth in a series of awards Embria has received over the past 18 months, including the Nutrition Business Journal Investment in the Future Award, the Greater Des Moines Partnership Economic Impact Award and the Master Builders of Iowa Masters Award.
Embria was selected for the Commercial Investment Award based on its creation of new employment opportunities within the community, as well as the local economic stimulus Embria brought with its newly constructed $10-million Ankeny headquarters.
"While the country's economic future is at a critical point, Embria is proud to be a steady contributor to Iowa’s economy since our 2005 inception," said Paul Faganel, president, Embria Health Sciences.
"With the completion of new clinical research on our flagship immune health ingredient, EpiCor(R), we see many more opportunities for job and economic growth throughout the year."
Embria Health Sciences, www.embriahealth.com, combines science and nature to bring high-quality, research-based natural ingredients to the global human nutrition market. Embria's key products are manufactured using a proprietary technology, which produces vital metabolites that deliver nutritional benefits and support increased bioavailability. A recently published study found Embria's flagship ingredient, the all-natural high-metabolite immunogen EpiCor, to significantly decrease the incidence and duration of cold and flu symptoms.
# # #